Page last updated: 2024-09-03

kf 17837s and 2-chloro-n(6)cyclopentyladenosine

kf 17837s has been researched along with 2-chloro-n(6)cyclopentyladenosine in 1 studies

Compound Research Comparison

Studies
(kf 17837s)
Trials
(kf 17837s)
Recent Studies (post-2010)
(kf 17837s)
Studies
(2-chloro-n(6)cyclopentyladenosine)
Trials
(2-chloro-n(6)cyclopentyladenosine)
Recent Studies (post-2010) (2-chloro-n(6)cyclopentyladenosine)
3900252043

Protein Interaction Comparison

ProteinTaxonomykf 17837s (IC50)2-chloro-n(6)cyclopentyladenosine (IC50)
Adenosine receptor A3Homo sapiens (human)0.0112
Adenosine receptor A1Homo sapiens (human)0.0009

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Conti, A; Dionisotti, S; Gatta, F; Ongini, E; Sandoli, D; Zocchi, C1

Other Studies

1 other study(ies) available for kf 17837s and 2-chloro-n(6)cyclopentyladenosine

ArticleYear
Effects of the new A2 adenosine receptor antagonist 8FB-PTP, an 8 substituted pyrazolo-triazolo-pyrimidine, on in vitro functional models.
    British journal of pharmacology, 1994, Volume: 112, Issue:2

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Cattle; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Phosphoric Diester Hydrolases; Platelet Aggregation; Purinergic P1 Receptor Antagonists; Pyrimidines; Quinazolines; Rabbits; Rats; Rats, Sprague-Dawley; Triazoles; Vasodilator Agents; Xanthines

1994